Covidien Cuts Costs in All Four Business Units, Corporate

Xconomy Boston — 

Covidien, the Bermuda-based healthcare products company that is one of the largest life sciences companies in Massachusetts, said today it is implementing a restructuring program that includes projects in all four of its business segments and in corporate. The company didn’t disclose any job cuts, although it said it plans to take a $200 million charge for the program, and that it will save $50 million to $75 million a year once it is completed. Covidien’s four business lines are medical devices, imaging solutions, pharmaceutical products, and medical supplies.